NDC 76420-231

Tizanidne hydrochloride

Tizanidne Hydrochloride

Tizanidne hydrochloride is a Oral Capsule in the Human Prescription Drug category. It is labeled and distributed by Asclemed Usa, Inc.. The primary component is Tizanidine Hydrochloride.

Product ID76420-231_e347f58a-9fc4-7e64-e053-2a95a90a528b
NDC76420-231
Product TypeHuman Prescription Drug
Proprietary NameTizanidne hydrochloride
Generic NameTizanidne Hydrochloride
Dosage FormCapsule
Route of AdministrationORAL
Marketing Start Date2019-03-29
Marketing CategoryANDA /
Application NumberANDA212196
Labeler NameAsclemed USA, Inc.
Substance NameTIZANIDINE HYDROCHLORIDE
Active Ingredient Strength6 mg/1
Pharm ClassesAdrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]
NDC Exclude FlagN
Listing Certified Through2023-12-31

Packaging

NDC 76420-231-30

30 CAPSULE in 1 BOTTLE (76420-231-30)
Marketing Start Date2022-07-07
NDC Exclude FlagN
Sample Package?N

Drug Details

NDC Crossover Matching brand name "Tizanidne hydrochloride" or generic name "Tizanidne Hydrochloride"

NDCBrand NameGeneric Name
63629-8871Tizanidne hydrochlorideTizanidne Hydrochloride
63629-8872Tizanidne hydrochlorideTizanidne Hydrochloride
63629-8873Tizanidne hydrochlorideTizanidne Hydrochloride
67296-1793Tizanidne hydrochlorideTizanidne Hydrochloride
67877-610Tizanidne hydrochlorideTizanidne Hydrochloride
67877-611Tizanidne hydrochlorideTizanidne Hydrochloride
67877-612Tizanidne hydrochlorideTizanidne Hydrochloride
68788-7962Tizanidne hydrochlorideTizanidne Hydrochloride
71335-2077Tizanidne hydrochlorideTizanidne Hydrochloride
76420-231Tizanidne hydrochlorideTizanidne Hydrochloride

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.